Quarterly report pursuant to Section 13 or 15(d)

SIGNIFICANT ACCOUNTING POLICIES (Tables)

SIGNIFICANT ACCOUNTING POLICIES (Tables)

6 Months Ended

Jun. 30, 2024

SIGNIFICANT ACCOUNTING POLICIES

Schedule of net sales

		Three Months Ended June 30,
		2024				2023
Sales/access fees		$	-			$	9,245
Distribution rights income			4,045				8,721
Membership/program fees			-				1,669
Net sales		$	4,045			$	19,635

		Six Months Ended June 30,
		2024				2023
Sales/access fees		$	2,205			$	10,255
Project support income			-				25,817
Distribution rights income			4,045				17,347
Membership/program fees			1,415				6,658
Net sales		$	7,665			$	60,077

Schedule of changes in deferred revenue

Balance as of December 31, 2023
Short term		$	-
Long term			4,045
Total as of December 31, 2023			4,045
Net sales recognized			(4,045	)
Balance as of June 30, 2024		$	-

Schedule of assets and liabilities measured at fair value on a recurring basis

		June 30, 2024
		Level 1				Level 2				Level 3				Total
Liabilities:
Derivative liability		$	-			$	-			$	80,190			$	80,190
		$	-			$	-			$	80,190			$	80,190

		December 31, 2023
		Level 1				Level 2				Level 3				Total
Liabilities:
Derivative liability		$	-			$	-			$	53,460			$	53,460
		$	-			$	-			$	53,460			$	53,460

Schedule of derivative liability

		Derivative Liability

Fair value as of December 31, 2023		$	53,460
Fair value at issuance			26,730
Fair value as of March 31, 2024			80,190
Fair value as of June 30, 2024		$	80,190

Schedule of weighted average diluted shares

		Six Months Ended
		June 30,
		2024				2023
Shares underlying options outstanding			995,187				882,869
Shares underlying warrants outstanding			1,765,856				850,856
Convertible preferred stock outstanding			240,000				240,000
			3,001,043				1,973,725